Showing results (1981-1990 of 2,148) with videos related to
Sort By:
Pageof 215
International Journal of Cardiology|November 21, 2025
TRI·Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repairAntonio Sisinni, Manuel Barreiro-Perez, Xavier Freixa, et al.The American Journal of Cardiology|January 21, 2022
Long-Term Intracoronary Structural and Vasomotor Assessment of the ABSORB Bioresorbable Vascular ScaffoldOmar Abdul-Jawad Altisent, Luis Renier Goncalves-Ramírez, Leticia Fernández, et al.Journal of the American College of Cardiology|August 3, 2019
Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve ReplacementTania Rodriguez-Gabella, Pablo Catalá, Antonio J Muñoz-García, et al.Journal of the American Heart Association|September 18, 2024
Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical TrialIgnacio J Amat-Santos, Diego López-Otero, Luis Nombela-Franco, et al.The American Journal of Cardiology|February 21, 2025
One-Year Recurrent Tricuspid Regurgitation After Successful Transcatheter Edge to Edge Repair: The TRI-SPA RegistryJulio Echarte-Morales, Pedro Cepas-Guillén, Dabit Arzamendi, et al.Medicina Clinica (English Ed.)|May 9, 2022
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysisÁlvaro Aparisi, Pablo Catalá, Ignacio J Amat-Santos, et al.Plos One|August 31, 2018
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyEdgar T Hoorntje, Anna Posafalvi, Petros Syrris, et al.Revista Espanola De Cardiologia (English Ed.)|March 28, 2025
Edge-to-edge tricuspid valve repair and heart failure hospitalizations: the TRI-SPA registryJulio Echarte-Morales, Laura Sanchis, Dabit Arzamendi, et al.American Heart Journal|February 3, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationaleElvin Kedhi, Andi Rroku, Rik S Hermanides, et al.REC, Interventional Cardiology|December 3, 2025
Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trialEva Bernal-Labrador, Rafael Romaguera, Sergio García-Blas, et al.Pageof 215